Unnatural analogues of sialic acid can be delivered to mammalian cell surfa
ces through the metabolic transformation of unnatural N-acetylmannosamine (
ManNAc) derivatives. In previous studies, mannosamine analogues bearing sim
ple N-acyl groups up to five carbon atoms in length were recognized as subs
trates by the biosynthetic machinery and transformed into cell surface sial
oglycoconjugates [Keppler, O. T.,et al. (2001) Glycobiology 11, 11R-18R]. S
uch structural alterations to cell surface glycans can be used to probe car
bohydrate-dependent phenomena. This report describes our investigation into
the extent of tolerance of the pathway toward additional structural altera
tions of the N-acyl substituent of ManNAc. A panel of analogues with ketone
-containing N-acyl groups that varied in the length or steric bulk was chem
ically synthesized and tested for metabolic conversion to cell surface glyc
ans. We found that extension of the N-acyl chain to six, seven, or eight ca
rbon atoms dramatically reduced utilization by the biosynthetic machinery.
Likewise, branching from the linear chain reduced metabolic conversion. Qua
ntitation of metabolic intermediates suggested that cellular metabolism is
limited by the phosphorylation of the N-acylmannosamines by ManAc 6-kinase
in the first step of the pathway. This was confirmed by enzymatic assay of
the partially purified enzyme with unnatural substrates. Identification of
ManNAc 6-kinase as a bottleneck for unnatural sialic acid biosynthesis prov
ides a target for expanding the metabolic promiscuity of mammalian cells.